Grifols (GIKLY) EBT Margin (2010 - 2019)
Grifols (GIKLY) reported EBT Margin of 14.93% for Q4 2019, up 20.89% quarter-over-quarter from 12.35% in Q1 2019.
Grifols (GIKLY) EBT Margin (2010 - 2019) Analysis & Trends
Grifols has reported EBT Margin for 9 years, with the latest figure at 14.93% in Q4 2019.
- For the quarter ending Q4 2019, EBT Margin changed N/A year-over-year to 14.93%; the trailing twelve-month figure through Dec 2019 stood at 21.95% (changed N/A YoY), and the FY2025 full-year result was 8.17%, down 22201.0% from the prior year.
- EBT Margin for Q4 2019 stood at 14.93%, up from 12.35% in the prior quarter.
- The five-year high for EBT Margin was 25.47% in Q3 2015, with the low at 12.35% in Q1 2019.
- Historically, EBT Margin has averaged 20.06% across 5 years, with a median of 20.05% in 2016.
- Annual changes were most pronounced in 2017 — EBT Margin soared 293 bps — and 2019, when it slumped 514 bps.
- Grifols' EBT Margin stood at 16.32% in 2015, then climbed by 6 bps to 17.38% in 2016, then jumped by 45 bps to 25.22% in 2017, then decreased by 5 bps to 23.85% in 2018, then sank by 37 bps to 14.93% in 2019.
- The last three EBT Margin figures came in at 14.93% (Q4 2019), 12.35% (Q1 2019), and 23.85% (Q2 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | 28.10% |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 44.70% |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 24.89% |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 6.93% |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | -21.49% |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 24.18% |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 37.07% |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 135.53% |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 28.20% |
| 10 | Grifols | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 14.93% |
| Mar 31, 2019 | 12.35% |
| Jun 30, 2018 | 23.85% |
| Mar 31, 2018 | 17.49% |
| Jun 30, 2017 | 25.22% |
| Dec 31, 2016 | 17.38% |
| Sep 30, 2016 | 23.95% |
| Jun 30, 2016 | 22.28% |
| Dec 31, 2015 | 16.32% |
| Sep 30, 2015 | 25.47% |
| Jun 30, 2015 | 23.62% |
| Mar 31, 2015 | 17.81% |
| Sep 30, 2013 | 18.83% |
| Jun 30, 2013 | 19.36% |
| Mar 31, 2013 | 18.33% |
| Dec 31, 2012 | 13.12% |
| Sep 30, 2012 | 15.06% |
| Jun 30, 2012 | 15.61% |
| Mar 31, 2012 | 15.43% |
| Dec 31, 2011 | 36.84% |